Vaxcell-Bio Therapeutics Co., Ltd. (KOSDAQ: 323990)

Vaxcell-Bio Therapeutics Balance Sheet

Financials in millions KRW. Fiscal year is January - December.

Fiscal Year	TTM	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019
Period Ending	Jun 30, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019
Cash & Equivalents	4,604	9,046	389.66	2,309	9,903	4,074
Short-Term Investments	45,000	41,000	20,002	25,000	9,000	4,000
Cash & Short-Term Investments	49,604	50,046	20,392	27,309	18,903	8,074
Cash Growth	214.08%	145.42%	-25.33%	44.47%	134.10%	-29.46%
Accounts Receivable	2.67	0.08	-	-	-	-
Other Receivables	1,853	581.97	210.31	353.21	96.63	96.31
Receivables	1,855	582.05	210.31	353.21	96.63	96.31
Inventory	158.09	96.74	-	-	-	-
Prepaid Expenses	118.04	185.45	190.31	504.84	70.66	90.75
Other Current Assets	332.03	316.92	105.7	30.62	116.37	55.81
Total Current Assets	52,067	51,227	20,898	28,197	19,186	8,317
Property, Plant & Equipment	6,571	2,674	2,541	2,804	1,142	1,557
Long-Term Investments	21,922	29,873	-0	-0	15,000	-0
Other Intangible Assets	1,230	206.65	229.46	147.62	68.82	77.48
Other Long-Term Assets	1,353	999.18	494.03	126.87	100.88	83.47
Total Assets	83,143	84,980	24,163	31,276	35,498	10,036
Accrued Expenses	154.79	117.87	118.23	129.42	188.94	221.77
Current Portion of Leases	973.74	216.89	46.51	183.05	186.36	162.99
Other Current Liabilities	1,193	589.38	142.3	79.84	218.89	40.96
Total Current Liabilities	2,322	924.14	307.04	392.3	594.19	425.73
Long-Term Leases	1,784	144.34	58.72	37.39	152.75	300.63
Other Long-Term Liabilities	430.62	269.63	219.11	112.64	20.84	-
Total Liabilities	4,868	1,487	835.78	1,196	830.1	964.46
Common Stock	11,497	11,497	7,612	7,612	3,762	3,254
Additional Paid-In Capital	115,619	115,619	48,888	48,888	51,913	23,054
Retained Earnings	-48,908	-43,537	-33,383	-26,505	-21,288	-17,359
Treasury Stock	-532.7	-532.7	-	-	-	-
Comprehensive Income & Other	599.8	447.51	210.35	85.39	280.14	121.16
Total Common Equity	78,275	83,493	23,327	30,080	34,667	9,071
Shareholders' Equity	78,275	83,493	23,327	30,080	34,667	9,071
Total Liabilities & Equity	83,143	84,980	24,163	31,276	35,498	10,036
Total Debt	2,757	361.23	105.24	220.44	339.11	463.62
Net Cash (Debt)	46,846	49,685	20,287	27,088	18,563	7,611
Net Cash Growth	203.07%	144.91%	-25.11%	45.92%	143.91%	199.50%
Net Cash Per Share	1995.00	2532.94	1064.12	1791.57	2725.80	1736.13
Filing Date Shares Outstanding	22.96	22.96	18.27	18.27	9.03	4.38
Total Common Shares Outstanding	22.96	22.96	18.27	18.27	9.03	4.38
Working Capital	49,745	50,303	20,591	27,805	18,592	7,892
Book Value Per Share	3408.50	3635.75	1276.97	1646.65	3840.16	2069.29
Tangible Book Value	77,045	83,287	23,098	29,933	34,599	8,994
Tangible Book Value Per Share	3354.95	3626.75	1264.41	1638.57	3832.54	2051.61
Land	1,602	1,602	1,602	1,602	-	-
Machinery	3,986	2,489	2,346	2,213	1,717	1,689
Construction In Progress	-	22.51	-	-	-	-

Source: S&P Capital IQ. Standard template. Financial Sources.